fesoterodine fumarate
Sponsors
Pfizer, Mayo Clinic, University of North Carolina, Chapel Hill
Conditions
HealthyOveractive BladderUrge Urinary IncontinenceUrinary Bladder, Overactive
Phase 1
Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit
TerminatedNCT00832650
Start: 2009-04-30End: 2009-12-31Updated: 2010-12-24
A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers
CompletedNCT01566760
Start: 2012-05-31End: 2012-07-31Updated: 2016-08-19
Phase 2
Phase 3
A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients
CompletedNCT00425100
Start: 2007-01-31End: 2007-10-31Updated: 2018-12-05
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
CompletedNCT00444925
Start: 2007-04-30End: 2008-07-31Updated: 2015-03-24
Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.
CompletedNCT00658684
Start: 2008-02-29End: 2009-08-31Updated: 2010-10-13
Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)
CompletedNCT01786967
Start: 2012-09-30End: 2017-12-31Updated: 2020-03-18
Phase 4
A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.
CompletedNCT00798434
Start: 2008-06-30End: 2010-09-30Updated: 2011-12-14
Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate
TerminatedNCT01605617
Start: 2012-06-30End: 2013-03-31Updated: 2014-02-05